Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    August 2017
  1. JIN L, Vu T, Yuan G, Datta PK, et al
    STRAP promotes stemness of human colorectal cancer via epigenetic regulation of the NOTCH pathway.
    Cancer Res. 2017 Aug 21. pii: canres.0286.2017.
    PubMed     Text format     Abstract available


    June 2017
  2. HOU PC, Li YH, Lin SC, Lin SC, et al
    Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness.
    Cancer Res. 2017 Jun 26. pii: canres.2990.2016.
    PubMed     Text format     Abstract available


  3. KONDELIN J, Gylfe AE, Lundgren S, Tanskanen T, et al
    Comprehensive evaluation of protein coding mononucleotide microsatellites in microsatellite-unstable colorectal cancer.
    Cancer Res. 2017 Jun 13. pii: canres.0682.2017.
    PubMed     Text format     Abstract available


  4. YOKOYAMA Y, Watanabe T, Tamura Y, Hashizume Y, et al
    Autocrine BMP-4 signaling is a therapeutic target in colorectal cancer.
    Cancer Res. 2017 Jun 13. pii: canres.0112.2017.
    PubMed     Text format     Abstract available


    May 2017
  5. KLOOSTERMAN WP, Coebergh van den Braak RRJ, Pieterse M, van Roosmalen MJ, et al
    A systematic analysis of oncogenic gene fusions in primary colon cancer.
    Cancer Res. 2017 May 16. pii: canres.3563.2017.
    PubMed     Text format     Abstract available


  6. TOMKOVICH S, Yang Y, Winglee K, Gauthier J, et al
    Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.
    Cancer Res. 2017;77:2620-2632.
    PubMed     Text format     Abstract available


  7. LANG M, Berry D, Passecker K, Mesteri I, et al
    HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.
    Cancer Res. 2017;77:2424-2438.
    PubMed     Text format     Abstract available


    April 2017
  8. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available


  9. HUANG B, Yang H, Cheng X, Wang D, et al
    tRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 26. pii: canres.3146.2016.
    PubMed     Text format     Abstract available


  10. KOTELEVETS L, Chastre E, Caron J, Mougin J, et al
    A squalene-based nanomedicine for oral treatment of colon cancer.
    Cancer Res. 2017 Apr 17. pii: canres.1741.2016.
    PubMed     Text format     Abstract available


  11. NIMANONG S, Ostroumov D, Wingerath J, Knocke S, et al
    CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations.
    Cancer Res. 2017;77:1918-1926.
    PubMed     Text format     Abstract available


  12. EDUATI F, Doldan-Martelli V, Klinger B, Cokelaer T, et al
    Drug resistance mechanisms in colorectal cancer dissected with cell type-specific dynamic logic models.
    Cancer Res. 2017 Apr 5. pii: canres.0078.2017.
    PubMed     Text format     Abstract available


    March 2017
  13. HSIAO KY, Lin YC, Gupta SK, Chang N, et al
    Non-coding effects of circular RNA CCDC66 promote colon cancer growth and metastasis.
    Cancer Res. 2017 Mar 1. pii: canres.1883.2016.
    PubMed     Text format     Abstract available


  14. TIE G, Yan J, Khair L, Messina J, et al
    Hypercholesterolemia increases colorectal cancer incidence by reducing production of NKT and gammadelta T cells from hematopoietic stem cells.
    Cancer Res. 2017 Mar 1. pii: canres.1916.2016.
    PubMed     Text format     Abstract available


  15. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Text format     Abstract available


  16. FANG M, Li Y, Huang K, Qi S, et al
    IL-33 promotes colon cancer cell stemness via JNK activation and macrophage recruitment.
    Cancer Res. 2017 Mar 1. pii: canres.1602.2016.
    PubMed     Text format     Abstract available


  17. MAHNE AE, Mauze S, Joyce-Shaikh B, Xia J, et al
    Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
    Cancer Res. 2017;77:1108-1118.
    PubMed     Text format     Abstract available


    February 2017
  18. BLAJ C, Schmidt EM, Lamprecht S, Hermeking H, et al
    Oncogenic effects of high MAPK activity in colorectal cancer mark progenitor cells and persist irrespective of RAS mutations.
    Cancer Res. 2017 Feb 15. pii: canres.2821.2016.
    PubMed     Text format     Abstract available


  19. TONG J, Wang P, Tan S, Chen D, et al
    Mcl-1 degradation is required for targeted therapeutics to eradicate colon cancer cells.
    Cancer Res. 2017 Feb 15. pii: canres.3242.2016.
    PubMed     Text format     Abstract available


    January 2017
  20. ROKAVEC M, Hermeking H
    Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs and epigenetic modifications associated with metastasis.
    Cancer Res. 2017 Jan 27. pii: canres.3236.2016.
    PubMed     Text format     Abstract available


  21. MATHOT L, Kundu S, Ljungstrom V, Svedlund J, et al
    Somatic ephrin receptor mutations are associated with metastasis in primary colorectal cancer.
    Cancer Res. 2017 Jan 20. pii: canres.1921.2016.
    PubMed     Text format     Abstract available


  22. REYNAUD C, Ferreras L, Di Mauro P, Kan C, et al
    Lysyl Oxidase Is a Strong Determinant of Tumor Cell Colonization in Bone.
    Cancer Res. 2017;77:268-278.
    PubMed     Text format     Abstract available


  23. VIENNOIS E, Merlin D, Gewirtz AT, Chassaing B, et al
    Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.
    Cancer Res. 2017;77:27-40.
    PubMed     Text format     Abstract available


  24. KANG DW, Lee SW, Hwang WC, Lee BH, et al
    Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.
    Cancer Res. 2017;77:142-152.
    PubMed     Text format     Abstract available


  25. TIAN X, Nguyen M, Foote HP, Caster JM, et al
    CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1alpha.
    Cancer Res. 2017;77:112-122.
    PubMed     Text format     Abstract available


    November 2016
  26. CEJAS P, Cavazza A, Yandava C, Moreno V, et al
    Transcriptional regulator CNOT3 defines an aggressive colorectal cancer subtype.
    Cancer Res. 2016 Nov 29. pii: canres.1346.2016.
    PubMed     Text format     Abstract available


  27. USHIJIMA T, Yoshino T
    The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer.
    Cancer Res. 2016;76:6443-6444.
    PubMed     Text format    


    October 2016
  28. ZHANG M, Xu C, Wen L, Han MK, et al
    A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells.
    Cancer Res. 2016 Oct 14. pii: canres.1681.2016.
    PubMed     Text format     Abstract available


  29. ESSIEN BE, Sundaresan S, Ocadiz-Ruiz R, Chavis A, et al
    Transcription factor ZBP-89 drives a feedforward loop of beta-catenin expression in colorectal cancer.
    Cancer Res. 2016 Oct 10. pii: canres.3150.2015.
    PubMed     Text format     Abstract available


    September 2016
  30. HORN T, Ferretti S, Ebel N, Tam A, et al
    High order drug combinations are required to effectively kill colorectal cancer cells.
    Cancer Res. 2016 Sep 22. pii: canres.3425.2015.
    PubMed     Text format     Abstract available


    August 2016
  31. DI CECILIA S, Zhang F, Sancho-Medina A, Li S, et al
    RBM-AS1 is critical for self-renewal of colon cancer stem-like cells.
    Cancer Res. 2016 Aug 12. pii: canres.1824.2015.
    PubMed     Text format     Abstract available


  32. LIMAGNE E, Euvrard R, Thibaudin M, Rebe C, et al
    Accumulation of MDSC and Th17 cells in patients with metastatic colorectal cancer predict the efficacy of a FOLFOX-bevacizumab drug treatment regimen.
    Cancer Res. 2016 Aug 5. pii: canres.3164.2015.
    PubMed     Text format     Abstract available


  33. BENJAMIN LE
    Commentary on "KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer".
    Cancer Res. 2016;76:4309-10.
    PubMed     Text format    


    July 2016
  34. DE LA CHAPELLE A
    Colon Cancer Germline Genetics: The Unbelievable Year 1993 and Thereafter.
    Cancer Res. 2016;76:4025-7.
    PubMed     Text format    


    June 2016
  35. SU L, Luo Y, Yang Z, Yang J, et al
    MEF2D transduces microenvironment stimuli to ZEB1 to promote epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Cancer Res. 2016 Jun 30. pii: canres.0246.2016.
    PubMed     Text format     Abstract available


  36. KUO WT, Lee TC, Yu LC
    Eritoran suppresses colon cancer by altering a functional balance in Toll-like receptors that bind lipopolysaccharide.
    Cancer Res. 2016 Jun 21. pii: canres.0172.2016.
    PubMed     Text format     Abstract available


  37. ODDO D, Sennott EM, Barault L, Valtorta E, et al
    Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer.
    Cancer Res. 2016 Jun 16. pii: canres.0396.2016.
    PubMed     Text format     Abstract available


    May 2016
  38. ALEKSANDROVA K, Giuseppe RD, Isermann B, Biemann R, et al
    Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC - Potsdam Cohort Study.
    Cancer Res. 2016 May 23. pii: canres.3464.2015.
    PubMed     Text format     Abstract available


  39. ZHOU J, Wang H, Zhang H, Lutz AM, et al
    VEGFR2-targeted three-dimensional ultrasound imaging can predict responses to anti-angiogenic therapy in preclinical models of colon cancer.
    Cancer Res. 2016 May 20. pii: canres.3271.2015.
    PubMed     Text format     Abstract available


  40. GIRAUD J, Failla LM, Pascussi JM, Lagerqvist EL, et al
    Autocrine secretion of progastrin promotes the survival and self-renewal of colon cancer stem-like cells.
    Cancer Res. 2016 May 4. pii: canres.1497.2015.
    PubMed     Text format     Abstract available


    April 2016
  41. FEHRINGER G, Kraft P, Pharoah PD, Eeles RA, et al
    Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.
    Cancer Res. 2016 Apr 20. pii: canres.2980.2015.
    PubMed     Text format     Abstract available


  42. HOUSSEAU F, Wu S, Wick EC, Fan H, et al
    Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
    Cancer Res. 2016;76:2115-24.
    PubMed     Text format     Abstract available


  43. SRINIVASAN T, Walters J, Bu P, Than EB, et al
    NOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer Initiating Cells.
    Cancer Res. 2016 Apr 11. pii: canres.3198.2015.
    PubMed     Text format     Abstract available


    March 2016
  44. RAYNAL NJ, Lee JT, Wang Y, Beaudry A, et al
    Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
    Cancer Res. 2016;76:1494-505.
    PubMed     Text format     Abstract available


    February 2016
  45. RAO CV, Sanghera S, Zhang Y, Biddick L, et al
    Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.
    Cancer Res. 2016;76:630-42.
    PubMed     Text format     Abstract available


  46. MARUSIAK AA, Stephenson NL, Baik H, Trotter EW, et al
    Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.
    Cancer Res. 2016;76:724-35.
    PubMed     Text format     Abstract available


    January 2016
  47. XING C, Lu XX, Guo PD, Shen T, et al
    Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
    Cancer Res. 2016;76:83-95.
    PubMed     Text format     Abstract available


  48. TAVARE R, Escuin-Ordinas H, Mok S, McCracken MN, et al
    An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
    Cancer Res. 2016;76:73-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: